HSIC vs IDXX
Henry Schein vs Idexx Laboratories — AI-powered side-by-side comparison
VS
IDXX
Idexx Laboratories
69
Buy
| Metric | HSIC | IDXX |
|---|
| AI Score |
65
|
69
|
| Price |
$88.16
|
$586.77
|
| P/E Ratio |
25.47×
|
41.20×
|
| ROE |
12.3%
|
66.0%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
30.3%
|
62.4%
|
| Debt / Equity |
1.21×
|
0.60×
|
| Dividend Yield |
0.0%
|
0.0%
|
| RSI (14) |
60.6
|
65.3
|
| Beta |
0.806
|
1.549
|
| Expected Upside |
+0.7%
|
+12.3%
|
AI Committee View
Current Innellis committee reasoning for HSIC versus IDXX.
IDXX leads by 4 points.
IDXX scores 69/100 (Buy) versus HSIC at 65/100 (Buy).
HSIC Committee View
75% agreement
4 analysts
The primary driver is market regime is bullish (bull market -- normal position sizing). The main limiting factor is growth rate is decelerating quarter over quarter -- the trend line matters more than the level. The committee is constructive but not yet at full conviction.
Bull Case
- 4 consecutive earnings beats -- consistent execution — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
IDXX Committee View
75% agreement
4 analysts
The primary driver is 5 consecutive earnings beats -- consistent execution. Most analysts agree, and no major concerns are blocking a stronger rating.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- Stochastic RSI (90.3) confirms overbought conditions.
- Both daily and weekly trends are bearish — strong multi-timeframe downtrend.